Author(s): Anna Sicuranza, Corrado Zuanelli Brambilla, Ilaria Ferrigno, et. al. EHA Library. Sicuranza A. Jun 14, 2019; 266220; PF420 Abstract: PF420 Session topic: 8. Chronic myeloid leukemia – Clinical Background Tyrosine kinase inhibitors (TKI) revolutionized treatment and prognosis of chronic myeloid leukemia (CML), but some patients (pts) still suffer from potentially severe...
Pro zobrazení tohoto obsahu je třeba být přihlášen.